Clinical Trial Update: Atrial Fibrillation: In Search for the Optimal Target for Rate Control [Phase 4]

View source ↗

Summary

Phase 4 study from The University of Hong Kong investigating the optimal rate-control target for atrial fibrillation and currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: The University of Hong Kong | Conditions: Atrial Fibrillation (Permanent), Atrial Fibrillation (AF) | Phase 4 | Status: NOT_YET_RECRUITING